A detailed history of Colonial Trust CO / Sc transactions in United Therapeutics Corp stock. As of the latest transaction made, Colonial Trust CO / Sc holds 19 shares of UTHR stock, worth $8,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 25 24.0%
Holding current value
$8,861
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$274.7 - $438.75 $1,648 - $2,632
-6 Reduced 24.0%
19 $7,000
Q2 2025

Aug 13, 2025

BUY
$276.47 - $328.4 $552 - $656
2 Added 8.7%
25 $7,000
Q1 2025

May 13, 2025

SELL
$304.42 - $380.78 $1,217 - $1,523
-4 Reduced 14.81%
23 $7,000
Q4 2024

Feb 14, 2025

BUY
$348.66 - $410.0 $6,624 - $7,790
19 Added 237.5%
27 $9,000
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $2,488 - $2,908
8 New
8 $2,000
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $5,507 - $6,454
26 New
26 $5,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.